Author
Nancy Gudgeon
0 works0 citations
Recent research
- BiologyOpen access
Selinexor potentiates NK cell activation against multiple myeloma
INTRODUCTION: Selinexor is a first in class selective inhibitor of nuclear export (SINE) targeting Exportin-1 (XPO1) and approved for the treatment of multiple myeloma (MM). Selinexor has previously been shown to enhance natural killer (NK) cell activation against lymphoma cells...